BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siegrist CM, Kinahan SM, Settecerri T, Greene AC, Santarpia JL. CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector. Sci Rep 2020;10:19307. [PMID: 33168908 DOI: 10.1038/s41598-020-76449-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 bin Umair M, Akusa FN, Kashif H, Seerat-e-fatima, Butt F, Azhar M, Munir I, Ahmed M, Khalil W, Sharyar H, Rafique S, Shahid M, Afzal S. Viruses as tools in gene therapy, vaccine development, and cancer treatment. Arch Virol. [DOI: 10.1007/s00705-022-05432-8] [Reference Citation Analysis]
2 Tang N, Zhang Y, Shen Z, Yao Y, Nair V. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines. CRISPR J 2021;4:477-90. [PMID: 34406035 DOI: 10.1089/crispr.2021.0017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pandey M, Ojha D, Bansal S, Rode AB, Chawla G. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases. Mol Aspects Med 2021;:101003. [PMID: 34332771 DOI: 10.1016/j.mam.2021.101003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]